Management of recurrent transudative pleural effusions: can we REDUCE unnecessary interventions?

Christopher R Gilbert^{1

2}, José M Porcel³

Affiliations

¹ Thoracic Surgery and Interventional Pulmonology, Swedish Cancer Institute, Seattle, WA, USA.
² Center for Lung Cancer Research in Honor of Wayne Gittinger, Seattle, WA, USA.
³ Pleural Medicine Unit, Dept of Internal Medicine, Arnau de Vilanova University Hospital, IRBLleida, University of Lleida, Lleida, Spain jporcelp@yahoo.es.

Free article

Editorial

Christopher R Gilbert et al. Eur Respir J. 2022.

Free article

. 2022 Feb 24;59(2):2101942.

doi: 10.1183/13993003.01942-2021. Print 2022 Feb.

Christopher R Gilbert^{1

2}, José M Porcel³

¹ Thoracic Surgery and Interventional Pulmonology, Swedish Cancer Institute, Seattle, WA, USA.
² Center for Lung Cancer Research in Honor of Wayne Gittinger, Seattle, WA, USA.
³ Pleural Medicine Unit, Dept of Internal Medicine, Arnau de Vilanova University Hospital, IRBLleida, University of Lleida, Lleida, Spain jporcelp@yahoo.es.

No abstract available

Conflict of interest statement

Conflict of interest: C.R. Gilbert has nothing to disclose. Conflict of interest: J.M. Porcel has nothing to disclose.

Randomised trial of indwelling pleural catheters for refractory transudative pleural effusions.
Walker SP, Bintcliffe O, Keenan E, Stadon L, Evison M, Haris M, Nagarajan T, West A, Ionescu A, Prudon B, Guhan A, Mustafa R, Herre J, Arnold D, Bhatnagar R, Kahan B, Miller RF, Rahman NM, Maskell NA. Walker SP, et al. Eur Respir J. 2022 Feb 24;59(2):2101362. doi: 10.1183/13993003.01362-2021. Print 2022 Feb. Eur Respir J. 2022. PMID: 34413152 Clinical Trial.